Future of Healthcare

Avalon Healthcare Solutions Announces New Collaboration with N.Y.-Based Health Insurer CDPHP

Avalon Healthcare Solutions | February 19, 2022

Avalon Healthcare Solutions, LLC, DBA Avalon Healthcare Solutions, is pleased to announce a new collaboration to provide genetic testing management to Capital District Physicians' Health Plan, Inc. (CDPHP®).

Lab testing is the gateway to appropriate diagnosis and treatment plans, and there are more than 13 billion lab tests performed annually in the U.S. Those results influence 70 percent of all medical decisions. Lab testing is highly complex and constantly evolving, creating challenges for health plans to navigate.

Avalon, the world's first Lab Insights company, takes lab benefit and value management services to the next level, further removing waste and abuse from the system, while also improving clinical outcomes. Avalon helps its clients provide earlier disease detection for their members and drive treatment protocols to accelerate the Triple Aim of improving the patient experience, improving the health of populations, and reducing the per member cost of healthcare.

Avalon and CDPHP are focused on using the latest technology, evidence-based medicine, and provider education to ensure high-quality, cost-effective laboratory services to drive appropriate care for CDPHP members. Avalon's innovative management services unlock the power of lab data, expanding the view to encompass the entire patient journey, optimizing treatment, improving outcomes, and driving down costs.

"We are pleased to join together with CDPHP and bring our proven history of management, as well as our innovative approach to unlocking new possibilities. The CDPHP focus on improving the health and well-being of its members and communities is perfectly aligned with Avalon's mission to help our clients enable value-driven care in this dynamic and increasingly challenging environment."

Bill Kerr, MD, Chief Executive Officer at Avalon

"For nearly 40 years, CDPHP has been committed to lowering the total cost of care while preserving the high-quality service our members and the community at-large have come to expect," said Elizabeth Warner, MD, Senior Vice President of Member Health, CDPHP. "This new venture with Avalon Healthcare Solutions will further our mission of ensuring care is delivered at the right place, at the right time, and with the best outcome possible for each and every member we serve."

About Avalon Healthcare Solutions
Avalon Healthcare Solutions is the world's first and only Lab Insights company, bringing together our proven Lab Benefit Management solutions, lab science expertise, digitized lab values, and proprietary analytics to help healthcare insurers proactively inform appropriate care, reduce costs, and improve clinical outcomes. Working with health plans across the country, the company covers more than 36 million lives and delivers 7-12% outpatient lab benefit savings. Avalon is pioneering a new era of value-driven care with its Lab Insights Platform that captures, digitizes, and analyzes lab results in real time to provide actionable insights for earlier disease detection, ensuring appropriate treatment protocols, and driving down overall cost. 

About CDPHP®
Established in 1984, CDPHP is a physician-founded, member-focused and community-based not-for-profit health plan that offers high-quality affordable health insurance plans to members in 29 counties throughout New York. 


MUSE NX - Cardiac information management with a friendlier IT integration.


MUSE NX - Cardiac information management with a friendlier IT integration.

Related News

Health Technology, Healthcare Analytics

Data Finds Intelligent Scheduling Linked to Improved Provider Utilization, Staff Efficiency

Businesswire | July 19, 2023

Recent analysis of operating data shows healthcare organizations using an intelligent scheduling solution drive strong performance improvements in strategically important areas, including clinical utilization, patient satisfaction and preventing errors that impact administrative workloads. The analysis, released by Relatient, the leading patient scheduling platform, provides insight into how important intelligent scheduling is to a healthcare organization’s success, and specifically uncovers how critical this function is to specialty care providers. Further, the data shows that scheduling tools that use data-driven algorithms, such as Relatient’s Dash Schedule solution, automate administrative tasks and improve patient interactions in ways that traditional appointment booking tools do not. As wait times continue to rise, especially for a patient trying to see a specialty physician, specialist healthcare organizations simultaneously struggle to ensure that providers schedules are accurate and capacity is properly utilized. Relatient’s analysis and insights point to guided, rules-based scheduling as a solution for this massive disconnect between patient demand and provider utilization. Specialty organizations using an intelligent scheduling solution have seen an average increase of 5-10% in physician utilization, with Gastroenterology, Orthopedic and Musculoskeletal, Urology and Multi-Specialty practices each maintaining between 87-98% physician utilization rates 98% Gastro (GI and GE) 93% Orthopedic 88% Urology 87% Multi–Specialty "Having the right, intelligent scheduling tools in place has been pivotal for not only our business operations but also patient care," said Andrew Wade, CEO at OrthoSC. "Fewer empty appointment spots means that people can get care even faster. We're able to respond more quickly to our community's care needs while also growing our practice with our existing staff and resources.” Another major disconnect between patients and providers is the way that patients make appointments. A recent survey found that 84% of provider organizations limit patients to only scheduling appointments through the front desk. Meanwhile, 61% of patients reported that they’ve skipped doctor appointments altogether due to challenges associated with scheduling, including being directed to schedule appointments via a traditional phone call. Relatient’s experience facilitating the appointment scheduling and management for over 50 million unique individuals in 2022 shows that organizations that provide a full self-service scheduling solution not only meet patient needs for ease-of-use and autonomy, but also drastically improve staff efficiency by taking tedious calendaring work off their plates Organizations utilizing Dash for online self-scheduling have seen up to 20% of appointments being scheduled online, with strong annualized growth in both new and established patient adoption. Organizations using Dash for online self-scheduling see an average of 32% of appointments being scheduled outside of business hours. “When consumers are demanding the ability to self-schedule, and administrators are increasingly burdened with new tasks and responsibilities, it just makes sense to transfer scheduling power into the hands of the patients. Traditional scheduling tools and even many native EHR capabilities don’t adequately account for complex and evolving provider needs and preferences,” said Jeff Gartland, CEO of Relatient. “It’s compelling to see how automating those rules within a tightly integrated scheduling tool has such a massive impact across all levels of care. Following this analysis, it’s clearer than ever that many challenges in healthcare are ubiquitous, but can also be solved with minimal disruption to a provider organization’s daily workflows.” About Relatient, Inc. Relatient, Inc., is the leading intelligent patient scheduling and engagement technology company that utilizes a data-led approach to improving access to care. Integrating with all leading EHR/PM systems, Relatient engages with over 50 million unique patients per year on behalf of provider groups and health systems across the U.S. Relatient’s intelligent self-scheduling, patient messaging, chat, digital registration and payment solutions drive operational efficiency, increased appointments, reduced no-shows, faster patient payments and improved patient satisfaction, all while supporting better health and care quality initiatives.

Read More

Healthcare Analytics

Verséa Health and iRemedy Announce Strategic Joint Venture

Businesswire | June 29, 2023

Verséa Health, Inc. a leading provider of diagnostics and medical supplies for urgent care centers, and iRemedy Healthcare Companies, Inc. (“iRemedy” or “the Company”), a pioneer in the medical supply ecommerce industry, are pleased to announce a strategic joint venture aimed at providing an integrated ecosystem of services designed uniquely to serve and enable the continued growth of urgent care facilities nationwide. The venture aims to address inefficiencies in the procurement process, bringing a much-needed solution to urgent care providers. The collaboration will leverage iRemedy's industry-leading procurement technology and Verséa's deep understanding of the urgent care sector to deliver a specialized platform that simplifies, streamlines, and enhances the supply purchasing process. Additionally, the platform will provide an expanded ecosystem of services such as tailored content and CME programs designed to support urgent care operations and their continued expansion of locations and service offerings. Tony Paquin, CEO of iRemedy, commented, “This partnership with Verséa is a significant step forward in our commitment to revolutionize the healthcare supply chain. By combining our respective strengths, we're confident that our new platform will significantly improve the procurement process, allowing urgent care providers to focus more on their primary mission - patient care.” Sean Fetcho, CEO of Verséa Health, added, “Verséa Health was born from a desire to transform healthcare to improve quality and access to care, and we believe urgent care centers are on the frontlines of much of that change. We've seen firsthand the challenges faced by urgent care centers, who are often overlooked or misunderstood by the traditional distributors, when looking for services or procuring medical supplies. Partnering with iRemedy and utilizing their robust ecommerce infrastructure allows us to deliver a seamless, efficient, and effective solution. This collaboration is a testament to Versea's commitment to supporting urgent care centers with innovative, practical solutions.” Further details of the new platform, including its official launch date, will be announced in due course. About Verséa Health, Inc. Verséa Health, Inc. headquartered in Tampa, FL, is a transformative healthcare company founded by experienced business executives and guided by an Advisory Board comprised of leading academic and multidisciplinary clinical medical advisors. Through strategic industry partnerships and proprietary research and development, the company delivers innovative, high-value diagnostic and therapeutic solutions to help improve healthcare quality and access. About The iRemedy Healthcare Companies iRemedy is a trusted and reliable partner for acquiring medical supplies. They service over 10,000 healthcare provider clients nationwide. iRemedy guarantees access to verified supplies by sourcing directly from established manufacturers and distributors around the world. Their industry-leading technology and group purchasing power enable transparency and competition, driving consistently low pricing for customers every day. iRemedy is headquartered in Stuart, Florida and has offices in New York, California and Washington, and a distribution center in Florida.

Read More

Healthcare Analytics

Clinical AI Pioneer Aidoc Partners with Ochsner Health to Transform Healthcare Delivery

PRNewswire | June 30, 2023

Aido announced a transformative partnership with Ochsner Health, a large healthcare system headquartered in New Orleans, operating 46 hospitals and more than 370 health and urgent care centers across the Gulf South. This partnership unites the clinical excellence of Ochsner with the power of Aidoc's advanced AI solutions, creating an alliance that advances the way healthcare is delivered, experienced and optimized across Louisiana and the Gulf South region. Ochsner has a proven track record as a leading adopter of emerging technologies and was an early adopter of integrating AI into patient care workflows. With the addition of Aidoc's clinical AI solutions and enterprise-wide AI platform, aiOS™, Ochsner is further empowering healthcare professionals and improving patient outcomes. "In the ever-evolving healthcare landscape, our teams at Ochsner Health are dedicated to harnessing emerging technologies to achieve our goals. We seek to leverage new technologies to deliver optimal outcomes without disrupting existing care processes," says Denise Basow, MD, Executive Vice President and Chief Digital Officer at Ochsner. "Aidoc possesses a deep understanding of the crucial challenges in implementing new technologies and have a proven track record of real-world impact that drives improved patient outcomes." Driven by a shared vision of advancing patient care, this partnership seeks to leverage emerging AI technology to drive tangible improvements across the healthcare landscape. Key objectives of this collaboration include Elevating Patient Care: Ochsner aims to further enhance patient outcomes by harnessing enterprise-wide AI solutions that can ensure it delivers the highest quality of care and patient safety in all communities it serves. Empowering Clinical Teams: The partnership is dedicated to supporting clinical teams by equipping them with advanced tools that alleviate stress and address burnout through automation and streamlined communication. Ochsner and Aidoc strive to enhance the capabilities of clinicians by supporting their decision-making processes. Pioneering Solutions: As leaders in the digital health landscape, Ochsner and Aidoc are committed to pushing the boundaries of innovation. Together, both organizations will actively explore new solutions that address industry needs and challenges, setting a new standard for healthcare excellence benefiting patients in the Gulf South and beyond. Advancing the Quadruple Aim: With a focus on improving patient outcomes, enhancing provider experiences, reducing costs and advancing population health, the partnership aligns closely with the quadruple aim in healthcare. With AI and digital health technologies, Ochsner continues its focus on creating a sustainable healthcare ecosystem that delivers value for all stakeholders. "Embracing innovation is not just a choice but a responsibility, especially when it comes to patient care," stated Louis Jeansonne, MD, Chief Medical Information Officer at Ochsner. "By integrating AI into our clinical workflows, and leveraging the data within our EHR, we empower our team and pave the way for advancements that directly impact patient outcomes. This collaboration with Aidoc underscores our commitment to embracing cutting-edge technologies that have the power to reshape the healthcare landscape and provide better care to our patients." Ochsner's enterprise agreement with Aidoc includes imaging AI algorithms that identify various suspected acute abnormalities in patient scans and enable cross-specialty teams to triage and coordinate care efficiently. Additionally, the agreement leverages Aidoc's proprietary aiOS™, a first-of-its-kind solution, helping facilities overcome challenges common to AI implementation, including integration with existing IT systems, the EHR, data management and reporting, while being flexible enough to grow and scale as patient care needs evolve. There is growing recognition from health systems that an enterprise-wide AI platform that runs effectively in any clinical setting and activates numerous AI applications at once can provide better outcomes – both clinical and financial – than a single, pathology-based AI algorithm. "Ochsner Health's unwavering dedication to innovation and trailblazing spirit is inspiring and is a testament to their continued pursuit of excellence," commented Elad Walach, CEO at Aidoc. "Our partnership is yet another proof point of how they embrace technology for true impact at the patient bedside. As we collaborate to integrate our enterprise-wide AI solutions, we are confident that our collective efforts will not only accelerate Ochsner's goals but also redefine the possibilities of patient care. Together, we will leverage the power of AI to drive transformative outcomes." About Aidoc Aidoc is a pioneering force in clinical AI. We focus on aiding and empowering healthcare teams to optimize patient treatment, which results in improved economic value and clinical outcomes. Our clinically proven AI solutions eliminate silos, increase efficiencies and improve outcomes by delivering critical information when and where care teams need it leading to immediate collective action. Built on Aidoc's exclusive aiOS™, we analyze and aggregate medical data to enable care teams to operationalize the unexpected and work seamlessly with a continued focus on the patient. Used in more than 1,000 medical centers worldwide, Aidoc has the most FDA clearances (13) in clinical AI and its AI-based solutions cover 75 percent of patient populations, enabling physicians to make informed decisions based on real-time data. Aidoc AI is always on, running in the background to change the foreground. Visit Aidoc.com to see how we are connecting all points of care with always on AI. About Ochsner Health Ochsner Health is an integrated healthcare system with a mission to Serve, Heal, Lead, Educate and Innovate. Celebrating more than 80 years of service, it leads nationally in cancer care, cardiology, neurosciences, liver and kidney transplants and pediatrics, among other areas. Ochsner is consistently named both the top hospital and top children's hospital in Louisiana by U.S. News & World Report. The not-for-profit organization is inspiring healthier lives and stronger communities through its Healthy State by 2030 initiative, a bold and collaborative plan to realize a healthier Louisiana. Its focus is on preventing diseases and providing patient-centered care that is accessible, affordable, convenient and effective. Ochsner Health pioneers new treatments, deploys emerging technologies and performs groundbreaking research, including 4,000 patients enrolled in 685 clinical studies in 2022. It has more than 37,000 employees and over 4,700 employed and affiliated physicians in over 90 medical specialties and subspecialties. It operates 46 hospitals and more than 370 health and urgent care centers across Louisiana, Mississippi, Alabama and the Gulf South; and its cutting-edge Connected Health digital medicine program is caring for patients beyond its walls. In 2022, Ochsner Health treated more than 1.4 million people from every state and 62 countries.

Read More